semaglutide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42573665
Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities.
Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities.
- 저자
- Rijuta Dhanraj Mukim, Yama Xu, Vito Evola, Mayur S Parmar
- 저널
- Molecular biology reports
- 공개일
- 2026 Aug 10
- 연구 유형
- 기타
- DOI
- 10.1007/s11033-026-12549-5
문헌 요약
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are established treatments for metabolic disease, with growing evidence suggesting neuroprotective potential in central nervous system (CNS) disorders. In preclinical models of Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and stroke, semaglutide has been reported to redu…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.